What if your skin could tell you
what it needs?
It starts with an itch.
You try cream after cream,
hoping one will be the solution.
We began by engineering a better cream.
But we asked a bigger question:
What if we could end the guesswork altogether?
We bring to you Bublé.
We are not building a skincare company.
We are building a skin intelligence platform.
pronounced "BOO-blay"
Our journey is a strategic evolution from addressing a single symptom to solving the root couse of the problem:
The
lack of personalized and evidence-based dermatological health.
This advancement is structured in three key phases.
Phase 1: The Foundtaion (Our iGEM Project)
We are creating a targeted cosmeceutical cream designed to relieve pruritus and replenish Filaggrin (FLG). This aims to establish market presence, build user trust, and generate the initial revenue to fuel our mission. This is where we are now.
Phase 2: The Biomarker Breakthrough (The "Proof")
We are engineering a proprietary, at-home rapid test kit that detects Filaggrin (FLG) deficiency—a key genetic biomarker for eczema. This transforms our value proposition. We move from "this cream might work" to "this test shows you why you need this cream." It provides tangible, scientific evidence that builds undeniable trust.
The underlying technology is currently under a patent filing process. Due to Hong Kong's strict public disclosure laws, technical details remain confidential at this stage.
Phase 3: AI Photo Diagnosis Platform
A multi-platform app is can be found on our website featuring an AI-powered skin analysis engine. Currently under development process, more info in software:
This is the gateway to our ecosystem:
- A user takes a picture of their skin.
- Our AI provides an instant, guided assessment.
- The platform creates a personalized action plan, for example:
Based on your results, ECZ01 would be best fitted for your profile."
More and more products to be added into our database, disease popularity as research priority.
Why This Model Wins
- Builds Trust: We move beyond generic marketing to offer evidence-based, personalized recommendations.
- Creates a High-Value Moat: The combination of patented diagnostics, AI software, and targeted therapeutics is difficult for competitors to replicate.
- Captures a Larger Market: We serve not only those who know they have eczema but also the vast "undiagnosed" population searching for answers to their skin issues.
- Generates Data: With user permission, the platform becomes a powerful tool for collecting real-world data on skin health, fueling future R&D and discovery.
Be the First to Experience the Future
The journey from a single cream to a complete skin intelligence ecosystem is underway. But every revolution starts with a first step.
And that first step is here, now.
